Coronavirus: Russia approves COVID-19 prescription drug for sale in pharmacies
Russia has now released a prescription drug to help outpatients ho have mild to moderate coronavirus symptoms, Reuters reports.
What’s going on?
Russia approved its new R-Pharm’s Coronavir treatment for sale in drug stores.
- The drug could be rolled out to pharmacies within the country over the next week or so, according to Reuters.
Coronavir and Avifavir are two prescription drugs for COVID-19 that are based off of Favipiravir, which was made in Japan to treat viruses, according to Reuters.
Don’t forget …
Coronavir received approval after a small clinical trial with 168 patients, Reuters reporters.
Russia continues to seek vaccine success
Russia’s potential coronavirus vaccine continues to go trough multiple trials to see its effectiveness, which I wrote about for Deseret.com.
A peer-reviewed study in The Lancet found Russia’s vaccine has had no major side effects.
- The trials “did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” the study’s authors wrote.
- “Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection.”